Heron Therapeutics, Inc. (HRTX) Profit Margins
Over the twelve months to 2026-06-30, Heron Therapeutics, Inc. (HRTX) had gross margin 70.1%, operating margin -7.2%, net margin -22.5%, free cash flow margin -8.0%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
HRTXHeron Therapeutics, Inc.Follow HRTX — free
—
Price chart with a free account
- Market cap
- 57.5M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 64.5% | 57.8% | 59.2% | 46.7% | 49.0% | 48.8% | 73.2% | 73.3% | 70.1% | |
| Operating margin | -237.4% | -144.3% | -257.4% | -252.3% | -162.2% | -87.1% | -8.0% | -1.6% | -7.2% | |
| Net margin | -230.8% | -140.3% | -256.4% | -255.6% | -169.1% | -87.0% | -9.4% | -13.0% | -22.5% | |
| FCF margin | -259.4% | -90.2% | -216.2% | -239.0% | -138.1% | -47.5% | -16.8% | -18.0% | -8.0% |
USD millions · SEC XBRL
Heron Therapeutics, Inc. — questions
- What is Heron Therapeutics, Inc.'s gross margin?
- 70.1% over the twelve months to 2026-06-30.
- What is Heron Therapeutics, Inc.'s operating margin?
- -7.2% over the twelve months to 2026-06-30.
- What is Heron Therapeutics, Inc.'s net profit margin?
- -22.5% over the twelve months to 2026-06-30.
Every figure on this page comes from Heron Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.